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CREATING A VALID AND RELIABLE BMT INPATIENT ACUITY TOOL THAT
REFLECTS CURRENT BMT NURSING PRACTICE AND WORKLOAD
Thirlwell, S., Rees, L., Beaupierre, A., Gillespie, M. Moffitt Cancer Cen-
ter, Tampa, FL
Blood and marrow transplant (BMT) is a complex treatment mo-
dality. Managers are challenged to determine appropriate staffing to
ensure safe, effective and efficient BMT nursing care. Tools to assess
patient acuity can assist managers to meet this staffing challenge. An
effective acuity tool reflects the complex and unique aspects of pa-
tient care and of the location where it will be used. Since 1993, the
BMT unit of our NCI-designated Cancer Center has used the
Bone Marrow Transplant Acuity Tool of Lovett and McMillan.
Given the tremendous changes in BMT care delivery, the BoneMar-
row Transplant Acuity Tool no longer reflects our present BMT
nursing, especially the care of the critically ill who remain on our
unit instead of being transferred to an intensive care unit. Challenges
arose in communication and justification of our staffing ratios as the
tool failed to measure patient care requirements, quantify nursing
workload, assist with allocation of staff or coordinate patient care de-
livery. BMT Nursing Leadership recognized the need to revise the
BMT-specific tool and create a new tool that is valid and reliable
for our present BMT care.
An ad hoc inpatient BMTAcuity Team was formed by the Patient
Care Manager (PCM) and included the clinical nurse specialist
(CNS) and experienced nurses. The Acuity Team followed the
LynnMethod to determine and quantify content validity (1986). Be-
ginning from the Bone Marrow Transplant Acuity Tool of 5 acuity-
levels including 49 indicators, members of the Acuity Team com-
pleted 4 rounds of an independent review to identify 40 indicators
with content validity established at a significance of p . .05. The
team met to quantify time of care associated with each indicator
and identified 5 acuity categories, differing in hours of care from
the original tool. Interrater reliability was established using two in-
dependent raters for 239 patients was high (r5 0.94, p\0.001).
The 2009 BMT Inpatient Acuity Tool is now in use on the BMT
unit and plans are underway to convert the tool to an electronic for-
mat. It has assisted the PCM and Clinical Leaders to communicate
staffing needs for safe and effective care of BMT patients on our
unit. In addition, it has assisted the BMT Nursing Leadership to
monitor changes in patient acuity over time as new BMT treatment
regimens and supportive care practices have been implemented. The
benefits and challenges of implementation of a new acuity tool will be
discussed.107
BEYOND NAUSEA & VOMITING: MONITORING LESS COMMON REAC-
TIONS TO HIGH DOSE BCNU
Kwan, H., Knight, S., Thirlwell, S. Moffitt Cancer Center, Tampa, FL
High dose carmustine (BCNU) is the first chemotherapy agent ad-
ministered as part of the conditioning regimen BEAM +/- R for au-
tologous blood and marrow transplantation (BMT) for lymphoma.
Nausea and vomiting are common adverse drug reactions (ADR)
to high dose BCNU and can be effectively controlled by administra-
tion of anti-emetics. Less common ADRs such as headache, facial
flushing, oral tingling, eye problems, dizziness and allergic reaction
have been reported but standardmethods of prevention and/or treat-
ment are not known.
The BMT Nursing unit-based Outcomes Management (OM)
Committee noticed an increase in less common BCNU ADRs.
Nurses expressed frustration that no standing orders were in place
to treat these ADRs. Patients’ anxiety levels increased as they expe-
rienced these effects on their first day of chemotherapy.
The OM Committee performed a retrospective analysis to track
the incidence of BCNUADRs.With the assistance of the RiskMan-
agement Department, the OM Committee reviewed safety reports
for BCNU submitted from June 2008 to May 2009. See Table 1. In-
terventions to treat these ADRs varied from slowing the infusion rate
to pharmacological intervention. The small number of reactions
made it difficult to determine the most effective intervention. The
OMCommittee felt that safety reports were not submitted for all re-actions and thus, did not reflect the true prevalence in our BEAM +/-
R patients. When discussed at staff meetings, nurses expressed un-
certainty regarding the purpose and process of safety reports. The
OM Committee identified the need to prospectively monitor pa-
tients receiving BEAM +/- R and submit safety reports for ADRs,
as needed. Tools were created to educate about less common
BCNU ADRs, to promote formal safety reports and to track pa-
tients. Within a month of implementation of new tools, an increase
in rate of reporting was noted with 7 out of 18 BEAM +/- R patients
reported to have a less common ADR.
The OM Committee will continue to monitor patients receiving
BEAM +/- R for six months and to collect data related to less com-
mon ADRs and interventions. Upon analysis of the data, results will
be presented to BMT Clinical Leadership to create standard orders
and information regarding the prevalence and treatment of less com-
mon ADRs will be incorporated into education of patients receiving
BEAM+/- R. In addition, knowledge gained from this project will be
shared with other BMT centers.
Table 1. Reported BCNUADRs from June 2008 to May 2009
N %BEAM 1/- Patients 93 –
BEAM 1/- Patients with ADRs 11 12 %
Eye problems 6 6.5 %
Jaw, tongue, speech changes 6 6.5 %
Nasal changes 5 5.4%
Tinnitus 1 1.1 %
Pruritus 1 1.1 %
Headache 1 1.1 %
Chills & rigors 1 1.1 %
Anaphylaxis 1 1.1 %108
MOTIVATED AND MOVING: A MULTIDISCIPLINARY INITIATIVE TO IN-
CREASE PATIENT PARTICIPATION IN PHYSICAL ACTIVITY
Tomczak, N.D.1, Faltus, K.J.1, Neumann, J.L.1, Morris, G.S.2 1 The
University of Texas M.D. Anderson Cancer Center, Houston, TX; 2 The
University of Texas M.D. Anderson Cancer Center, Houston, TX
Prolonged length of stay, in addition to disease and treatment re-
lated complications, can contribute to deconditioning in the Stem
Cell Transplantation (SCT) patient population. A multidisciplinary
group was formed to explore ways to encourage SCT patients to in-
crease their physical activity level while in the hospital. The result
was the Motivated &Moving (M&M) Program – an incentive based
program focusing on motivating patients to participate in physical
activity outside of their hospital room.
The program, developed by nurses and physical and occupational
therapists, employed a progressive rewards system, which acknowl-
edged SCT patients for participating in activities outside of their
hospital room such as ambulation, attendance at exercise class, or
work with the physical or occupational therapist. Patients were re-
warded with a paper circle (m&ms) for each activity performed out-
side their room. After accumulating 15 m&m points, patients then
received a colored bandana and pennant to recognize completion
of this level of achievement. A maximum of four such levels of
achievement were possible.
Implementation of this program in the SCT patient population
has proven to increase motivation for and participation in physical
activity while in the hospital. The program was evaluated through
a post-participation survey which revealed: 95% felt motivated to
participate in physical activity; 97% stated that physical activity
was important to the success of their transplant; 66% stated that their
fatigue was moderately to significantly improved; and 82% stated
that they felt better able to perform ADLs. In addition to patient sat-
isfaction, the program also fostered a greater sense of community on
the transplant unit among the patients, caregivers, and clinical staff.
The program also increased nursing encouragement of patient par-
ticipation in physical activity.
This program has the potential for bringing out subjective and ob-
jective improvements in the quality of life and clinical outcomes of
HSCT patients.
